I think they going to be closer to $5 on 1% of the market, if Japan is selling for $70 and making a profit and covering all costs.
Even if sales are $680 ( which the company indicated they would be likely be above ) per month per patient, and you said US cost was double the JDM for manufacture / sales / transport etc... so only $500 profit per unit. ( or 134 million in costs for 338 million in sales)
That gives Aus market cap of 6.7 Billion ... or $4.20 per share with PE 20:1
I think they going to be closer to $5 on 1% of the market, if...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 28.0¢ | $1.405M | 4.899M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 200490 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 345394 | 4 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.3¢ |
Change
-0.005 ( 3.68 %) |
||||
| Open | High | Low | Volume | ||
| 29.5¢ | 29.5¢ | 28.0¢ | 2039177 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| BOT (ASX) Chart |